← Back to Home

Stem Cell Culture Supernatant, PRP, and Exosomes: What's the Difference in Aesthetic Treatment?

4 min read
Stem Cell Culture Supernatant, PRP, and Exosomes: What's the Difference in Aesthetic Treatment?
On This Page

Search for regenerative aesthetics and three terms tend to appear side by side, often without much explanation of how they differ: platelet-rich plasma (PRP), exosomes, and stem cell culture supernatant. They are related but distinct materials, prepared differently, and supported by different amounts of research.

Platelet-rich plasma

PRP is made from a patient's own blood. A blood sample is centrifuged to separate and concentrate platelets, which release growth factors involved in tissue repair when activated. Because PRP is autologous — derived from the same person receiving it — it does not require donor cell processing.

Exosomes and stem cell culture supernatant

Exosomes are small vesicles that cells release as part of normal cell-to-cell communication. Stem cell culture supernatant is the liquid left behind after stem cells have been grown in a laboratory culture; it contains exosomes along with other proteins and signaling molecules the cells secreted during culture. Unlike PRP, these formulations are not made from the patient's own blood at the time of treatment — they come from cells cultured separately, under laboratory conditions.

A 2025 review in *Stem Cell Research & Therapy* describes exosomes acting through several mechanisms relevant to skin aging: influencing signaling pathways tied to cell growth and inflammation, and supporting collagen-related processes in skin tissue. The same review is direct about the limits of current evidence — it identifies production standardization, batch-to-batch consistency, and a lack of uniform manufacturing protocols as open challenges the field has not resolved. That is a meaningfully different evidence picture than a treatment with decades of standardized clinical use.

Why the distinction matters for a patient

These are not interchangeable options where you simply pick a preference. They differ in source (a patient's own blood vs. laboratory-cultured cells), in how much clinical history each has, and in what a receiving physician can honestly tell you about expected results. A physician-led aesthetic consultation should walk through which formulation, if any, fits a specific concern — not present all three as equally proven paths to the same outcome.

StemCellor coordinates aesthetic consultations in Japan where a licensed physician reviews your skin or scalp concern in person before recommending a formulation. More detail on how these sessions are structured is on our Regenerative Skin & Scalp Therapy page, and our Skin Aging page discusses common concerns patients bring to that conversation.

What this article is not saying

None of these formulations reverses the aging process, and no specific cosmetic outcome is guaranteed by any of them. Individual response varies, and candidacy for a given formulation depends on an in-person skin assessment, not on reading a comparison article. Reference pricing by formulation is listed on our Pricing page, with the final plan confirmed after consultation.

Frequently asked questions

Is one of these formulations simply better than the others?

Not in a way that applies to everyone. They differ in source, mechanism, and evidence base, and which one — if any — may be appropriate depends on the individual concern a physician reviews during consultation.

Is exosome or supernatant therapy backed by the same level of research as PRP?

No. PRP has a longer clinical history across multiple fields of medicine. Exosome and stem cell culture supernatant research is active and growing, but a 2025 peer-reviewed review specifically notes unresolved standardization and manufacturing-consistency challenges in this area.

Can this article tell me which formulation is right for me?

No. This is general background information, not an individual recommendation. A physician reviews your specific skin or scalp concern during an in-person consultation before discussing which formulation, if any, may be appropriate.

References

Liang C, Yi Y, Li J, Aghayants S, Chen X, Cao W, Zhang Q. "Unveiling exosomes in combating skin aging: insights into resources, mechanisms and challenges." Stem Cell Research & Therapy. 2025;16. DOI: 10.1186/s13287-025-04620-y

This article is general information prepared by the StemCellor editorial team. It is not medical advice, a diagnosis, or a treatment recommendation.

About This Article

Written by StemCellor Editorial Team

Source: Stem Cell Research & Therapy (Springer Nature, 2025 review)

This article was drafted with AI assistance as part of our content research process.

This article is intended for general educational purposes and does not constitute individual medical advice or a diagnosis. Please consult a licensed physician about your specific situation before making any treatment decision.

Continue Reading

Related planning questions to explore next.

More from the Journal
Private Case Review

Let us understand the case before anyone recommends a plan.

Share your goals, medical background, and travel window. StemCellor will help organize the next step around physician review, realistic expectations, timing, and reference cost.

Direct messaging channels are still being confirmed — for now, start through the international patient guide.

A private review table with a tea cup, closed folio, and folded documents in a quiet Japanese interior
Prepare an Inquiry
01
Share your background

Send the main concern, treatment goals, and any medical history that may affect candidacy.

02
Review the right pathway

We help clarify which treatment area may be worth discussing before travel is planned.

03
Coordinate the next step

When appropriate, the case is prepared for physician review and visit planning in Japan.

Open consultation chat